As part of a positive feedback loop, active IL-1β binds to IL-1 receptors (IL-1R) on cancer cells and further stimulate NF-κB signaling, thus inducing the expression of pro-inflammatory cytokines TNF-α and IL-6 and sustaining NF-κB-mediated chronic inflammation (37–39). Here, NFKB1 is linked to cancer.